Sarcoma: all 1,691 studies

Page 17 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.

• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
• Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractCompletedNCT00003334Phase 2
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003316Phase 2
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• Vinorelbine in Treating Children With Recurrent or Refractory CancersCompletedNCT00003234Phase 2
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00003212Phase 3
• Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersCompletedNCT00003207Phase 1
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003156Phase 2
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusCompletedNCT00003128Phase 3
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or RhabdomyosarcomaCompletedNCT00003081Phase 1
• Troglitazone in Treating Patients With LiposarcomaCompletedNCT00003058Phase 2
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the UterusTerminatedNCT00003054Phase 2
• Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00003052Phase 3
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With CancerCompletedNCT00003023Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00003008Phase 2
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaCompletedNCT00002995Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the UterusTerminatedNCT00002993Phase 2
• Doxorubicin in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002985Phase 3
• Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced SarcomaCompletedNCT00002974Phase 2
• Altretamine and Etoposide in Treating Patients With HIV-Related CancerCompletedNCT00002936Phase 1
• Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue SarcomaCompletedNCT00002898Phase 3
• Cryosurgery in Treating Patients With Soft Tissue SarcomaTerminatedNCT00002863Phase 1
• Docetaxel in Treating Children With Recurrent Solid TumorsCompletedNCT00002825Phase 2
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue SarcomaCompletedNCT00002804Phase 2
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue SarcomaCompletedNCT00002791Phase 2
• Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusCompletedNCT00002706Phase 3
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorCompletedNCT00002643Phase 2
• Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00002641Phase 3
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the UterusCompletedNCT00002546Phase 3
• Chemotherapy in Treating Patients With Advanced SarcomaCompletedNCT00002526Phase 2
• Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's SarcomaStatus unknownNCT00002516Phase 3
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2
• Combination Chemotherapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00002492Phase 2
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT00002485
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerCompletedNCT00002466Phase 2
• Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the UterusCompletedNCT00002459Phase 3
• Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS PatientsCompletedNCT00002445Phase 3
• A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002439Not applicable
• The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's SarcomaCompletedNCT00002366Phase 2
• A Study of Tecogalan SodiumCompletedNCT00002342Phase 1
• A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00002319Phase 3
• A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's SarcomaStatus unknownNCT00002318Phase 3
• A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's SarcomaCompletedNCT00002314Phase 2
• A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's SarcomaCompletedNCT00002262Phase 1
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's SarcomaCompletedNCT00002259Phase 2
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002226Not applicable
• A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002212Phase 2
• Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton PharmaceuticalsCompletedNCT00002189Phase 2
• A Study of ALRT1057 in Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002188Phase 2
• A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3CompletedNCT00002185Phase 2
• Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.CompletedNCT00002167Phase 2
• Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative DisordersCompletedNCT00002153Phase 1
• Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.CompletedNCT00002147Phase 3
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.CompletedNCT00002138Phase 1
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4CompletedNCT00002137Phase 1
• A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 DaysCompletedNCT00002136Phase 1
• A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's SarcomaCompletedNCT00002131Phase 2
• Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00002105Phase 3
• A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.CompletedNCT00002093Phase 3
• Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesCompletedNCT00001686
• Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the ExtremityCompletedNCT00001577Phase 1
• A Phase I Study of SU101 in Pediatric Patients With Refractory MalignancyCompletedNCT00001573Phase 1
• A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasCompletedNCT00001564Phase 2
• Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated CancersCompletedNCT00001560
• Twins Study of Gene Therapy for HIV InfectionCompletedNCT00001535Phase 1
• New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and NeuroblastomaCompletedNCT00001335Phase 2
• A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue SarcomaCompletedNCT00001300Phase 3
• Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility AntigensCompletedNCT00001294
• A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal TumorsCompletedNCT00001209Phase 1
• The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue TumorsCompletedNCT00001189Phase 2
• The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the ExtremitiesCompletedNCT00001188Phase 2
• A Study of Patients With AIDS SyndromeCompletedNCT00001120
• The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaCompletedNCT00001114Phase 2
• A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00001113Phase 1
• Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDSCompletedNCT00001059Phase 2
• A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00000996Phase 2
• A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00000994Phase 3
• A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDSCompletedNCT00000987Phase 1
• A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00000954Phase 1
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic ChemotherapyCompletedNCT00000807Phase 2
• A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's SarcomaCompletedNCT00000769Phase 1
• A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNCT00000763Phase 1
• A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNCT00000725Phase 1
• Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's SarcomaCompletedNCT00000695Phase 1
• A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's SarcomaCompletedNCT00000694Phase 1
• Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's SarcomaCompletedNCT00000687Phase 2
• A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's SarcomaCompletedNCT00000681Phase 1
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's SarcomaCompletedNCT00000660Phase 1

← Sarcoma overview